Condition: EDS · Cataplexy · Fatigue · Sponsor: Harmony Biosciences Management, Inc.
This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating excessive daytime sleepiness (EDS), cataplexy, sleepiness/wakefulness, and fatigue in adult participants (ages ≥18 years) with narcolepsy.
This description comes directly from the study's public registry record.
Michelle Manuel · 847-903-4610 · clinicaltrials@harmonybiosciences.com
Katie Wilmsen · 443-309-5556 · clinicaltrials@harmonybiosciences.com
Always discuss trial participation with your own doctor first.
| Phoenix Medical Group, PC | Peoria, Arizona, United States | Recruiting |
| Santa Monica Clinical Trials | Los Angeles, California, United States | Recruiting |
| Alpine Clinical Research Center, Inc | Boulder, Colorado, United States | Recruiting |
| PharmaDev Clinical Research Institute, LLC | Miami, Florida, United States | Recruiting |
| Central Florida Pediatric Sleep Disorders Institute | Winter Park, Florida, United States | Recruiting |
| Neurotrials Research Inc | Atlanta, Georgia, United States | Recruiting |
| Sleep Practitioners, LLC | Macon, Georgia, United States | Recruiting |
| Intrepid Research, LLC | Cincinnati, Ohio, United States | Recruiting |
| Respiratory Specialists | Wyomissing, Pennsylvania, United States | Recruiting |
| Lowcountry Lung and Critical Care PA | Charleston, South Carolina, United States | Recruiting |
| Bogan Sleep Consultants, LLC | Columbia, South Carolina, United States | Recruiting |
| Southwest Family Medicine | Dallas, Texas, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07675135